ResMed Inc. (RMD) To Go Ex-Dividend on November 12th

ResMed Inc. (NYSE:RMD) announced a quarterly dividend on Thursday, October 29th. Shareholders of record on Thursday, November 12th will be paid a dividend of $0.66 per share by the medical equipment provider on Thursday, December 17th. This represents a $2.64 annualized dividend and a yield of 1.1%. The ex-dividend date is Thursday, November 12th.

ResMed has increased its dividend payment by an average of 0.1% annually over the last three years and has increased its dividend every year for the last 13 years. ResMed has a payout ratio of 25.0% meaning its dividend is sufficiently covered by earnings. Analysts expect ResMed to earn $13.20 per share next year, which means the company should continue to be able to cover its $2.64 annual dividend with an expected future payout ratio of 20.0%.

ResMed Trading Up 0.1%

NYSE:RMD opened at $235.53 on Tuesday. The company has a market cap of $33.13 billion, a PE ratio of 20.86, a P/E/G ratio of 1.46 and a beta of 0.77. The business’s 50 day moving average is $231.82 and its two-hundred day moving average is $224.76. The company has a quick ratio of 1.88, a current ratio of 2.65 and a debt-to-equity ratio of 0.04. ResMed has a 52 week low of $180.26 and a 52 week high of $277.67.

ResMed (NYSE:RMD) last issued its quarterly earnings results on Thursday, October 29th. The medical equipment provider reported $2.91 earnings per share for the quarter, beating analysts’ consensus estimates of $2.67 by $0.24. The business had revenue of $1.41 billion during the quarter, compared to the consensus estimate of $1.39 billion. ResMed had a return on equity of 26.42% and a net margin of 27.79%. The business’s quarterly revenue was up 5.9% on a year-over-year basis. During the same period in the previous year, the business earned $2.55 EPS. On average, analysts predict that ResMed will post 12.14 EPS for the current year.

About ResMed

ResMed is a medical technology company that develops products and software for people with sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. Its devices include continuous positive airway pressure (CPAP) and bilevel machines, ventilators and related masks and accessories.

The company also provides cloud-connected software for managing sleep and respiratory care, along with digital tools used by home medical equipment providers and post-acute care organizations.